Financhill
Back

Regeneron Pharmaceuticals Vs. AbbVie Industry Stock Comparison

Sell
39

REGN
Regeneron Pharmaceuticals

Last Price:
742.92
Seasonality Move:
14.6%
Sell
31

ABBV
AbbVie

Last Price:
167.73
Seasonality Move:
6.01%
Sell
39
Regeneron Pharmaceuticals (REGN) is a Sell

Is Regeneron Pharmaceuticals a Buy, Sell or Hold?

  • The current Regeneron Pharmaceuticals [REGN] share price is $743.35. The Score for REGN is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • REGN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
31
AbbVie (ABBV) is a Sell

Is AbbVie a Buy, Sell or Hold?

  • The current AbbVie [ABBV] share price is $167.76. The Score for ABBV is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • ABBV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

REGN Stock Price Chart

What is Regeneron Pharmaceuticals's stock price today?

  • The Regeneron Pharmaceuticals share price today is $743.35
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing slight buying pressure.

ABBV Stock Price Chart

What is AbbVie's stock price today?

  • The AbbVie share price today is $167.76
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABBV is experiencing buying pressure, which is a positive indicator for future bullish movement.

REGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -62 Sell
Relative Strength Index (14 RSI): 13.08 Sell
Chaikin Money Flow: 151 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (783.29 - 941.63) Sell
Bollinger Bands (100): (917.99 - 1161.21) Sell

ABBV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -7.33 Sell
Relative Strength Index (14 RSI): 27.71 Sell
Chaikin Money Flow: 5412946 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (173.19 - 199.81) Sell
Bollinger Bands (100): (176.27 - 198.69) Sell

REGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 780.04 Sell
20-day SMA: 834.53 Sell
50-day SMA: 964.64 Sell
200-day SMA: 1003.34 Sell
8-day EMA: 775.42 Sell
20-day EMA: 832.12 Sell
50-day EMA: 927.66 Sell
200-day EMA: 978.17 Sell

ABBV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 168.89 Sell
20-day SMA: 186 Sell
50-day SMA: 190.37 Sell
200-day SMA: 178.8 Sell
8-day EMA: 172.04 Sell
20-day EMA: 181.09 Sell
50-day EMA: 186.82 Sell
200-day EMA: 178.66 Sell

Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.42 per share, and an increase next year of $0.41 per share.

AbbVie Earnings Growth & ABBV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $1.21 per share.

Regeneron Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

AbbVie Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):